June 5 - 6, 2024*
Immunize Colorado and the Colorado Department of Public Health and Environment (CDPHE) Immunization Branch will host the Epidemiology and Prevention of Vaccine-Preventable Diseases Course (also known as the "Pink Book") from June 5 - 6, 2024 in Denver, Colorado. The course is presented by the Centers for Disease Control and Prevention (CDC).
*A separate supplementary update on the state of immunizations in Colorado will be presented by local immunization experts on the afternoon of June 4 and is included in registration. Continuing education credit is not offered for this portion of the event.
Course Overview and Objectives
Faculty from the Centers for Disease Control and Prevention (CDC) will present a comprehensive review of immunization principles, as well as vaccine-preventable diseases and the recommended vaccines to prevent them. This two-day course will feature the most up-to-date immunization information from the Advisory Committee on Immunization Practices (ACIP).
Potential topics to be covered:
- Hepatitis B
- DTaP and Tdap
- Hepatitis A
After attending this conference, participants will be able to:
- Describe the difference between active and passive immunity
- Compare and contrast the characteristics of live, attenuated vaccines and inactivated vaccines
- For each vaccine-preventable disease, identify those for whom routine immunization is recommended
- Describe the characteristics of the vaccine(s) used to prevent each disease
- Describe emerging immunization issues related to pediatric, adolescent, and adult immunization
- Implement disease detection and prevention health care services to prevent health problems and maintain health
Who Should Attend
This course is designed for anyone seeking the most comprehensive and current knowledge of immunization, including physicians, nurses, nurse practitioners, physician assistants, medical assistants, pharmacists, immunization providers, program managers, nursing and medical students, and other medical support staff. Participants will need to have a basic understanding of biology and immunization.
Registration will open on January 30, 2024.
- Early Bird Registration - $200 (January 30 – February 29)
- Regular Registration - $250 (March 1 – May 9)
- Late Registration* - $290 (May 10 – May 23)
*If not sold out
Registration fees include an afternoon snack on June 4, lunch and an afternoon snack on June 5 and June 6, and continuing education credit (pending).
Cancellation and Refund Policy
Refunds will be given only for registration fees and do not include any travel, lodging, or other fees associated with the Pink Book Course. To qualify for a full refund, cancellations must occur on or before May 9, 2024. Partial refunds may be provided after that date at the discretion of course staff.
Immunize Colorado has secured a room block at Double Tree Cherry Creek for the evenings of June 2-5. The room fee is $189/night before taxes and fees, with the option to upgrade if needed. The room fee includes breakfast for single occupancy (a $15 charge will apply for each additional person). All rooms must be booked by May 20, 2024.
Double Tree Cherry Creek
455 S Colorado Blvd
Denver, CO 80246
Event Hosted By:
EXHIBITOR AND SPONSORSHIP OPPORTUNITIES
Consider exhibiting at or sponsoring the 2024 Pink Book Course! This is an excellent opportunity to connect with healthcare providers and public health professionals from across Colorado. To learn about exhibitor and sponsorship opportunities, view the 2024 Pink Book sponsorship and exhibitor package or contact us. Please note that due to Immunize Colorado's policy not to accept funding from vaccine manufacturers or distributors, these entities cannot sponsor or exhibit at the Pink Book Course.
Continuing Education credit
Continuing education (CE) for RP4522 Epidemiology and Prevention of Vaccine-Preventable Diseases will be provided through CDC TRAIN. If you have any questions, you may contact the CE Coordinator at NCIRD, Melissa Barnett at MBarnett2@cdc.gov or the CDC TRAIN Team at email@example.com.
In support of improving patient care, The Centers for Disease Control and Prevention is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
CME: The Centers for Disease Control and Prevention designates this Live course activity for a maximum of 14.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
CNE: The Centers for Disease Control and Prevention designates this activity for 14.5 nursing contact hours.
CPE: The Centers for Disease Control and Prevention designated this knowledge-based event for pharmacists to receive 1.45 CEUs (14.5 contact hours) in pharmacy education. The Universal Activity Number will be announced during the course. After credit is claimed, an unofficial statement of credit is immediately available on CDC TRAIN. Official credit will be uploaded within 60 days on NABP/CPE Monitor.
CEU: The Centers for Disease Control and Prevention is authorized by IACET to offer 1.45 CEUs for this program.
CECH: Sponsored by the Centers for Disease Control and Prevention, a designated provider of continuing education contact hours (CECH) in health education by the National Commission for Health Education Credentialing, Inc. This program is designed for Certified Health Education Specialists (CHESⓇ) and/or Master Certified Health Education Specialist (MCHESⓇ) to receive up to 14.5 total Category 1 continuing education contact hours. Maximum advanced level continuing education contact hours available are 14.5. Continuing Competency credits available are 14.5. CDC provider number 98614.
For Certified Public Health Professionals (CPH): The Centers for Disease Control and Prevention is a preapproved provider of Certified in Public Health (CPH) recertification credits and is authorized to offer 14.5 CPH recertification credits for this program.
DISCLOSURE: In compliance with continuing education requirements, all planners and presenters must disclose all financial relationships, in any amount, with ineligible companies during the previous 24 months as well as any use of unlabeled product(s) or products under investigational use. CDC, our planners, and presenters wish to disclose they have no financial relationship(s) with ineligible companies whose primary business is producing, marketing, selling, reselling, or distributing healthcare products by or on patients.
This educational activity may contain discussion of published and/or investigational uses of agents recommended by the Advisory Committee on Immunization Practices that are not indicated by the Food and Drug Administration.
CDC did not accept financial or in-kind support from any ineligible company for this continuing education activity.
FEES: No fees are charged for CDC's CE activities.